US 10689373
1,2-substituted cyclopentanes as orexin receptor antagonists
granted A61KA61K31/44A61K31/4439
Quick answer
US patent 10689373 (1,2-substituted cyclopentanes as orexin receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/44, A61K31/4439, A61K31/4965, A61K31/497